Answers are grounded in this paper and cite their sources.
Experimental study demonstrates high-throughput in vivo CRISPR mutagenesis in zebrafish, highlighting a scalable platform for vertebrate functional genomics.
CRISPR-Cas9 can be scaled up for large-scale screens in cultured cells, but CRISPR screens in animals have been challenging because generating, validating, and keeping track of large numbers of mutant animals is prohibitive. Here, we introduce Multiplexed Intermixed CRISPR Droplets (MIC-Drop), a platform combining droplet microfluidics, single-needle en masse CRISPR ribonucleoprotein injections, and DNA barcoding to enable large-scale functional genetic screens in zebrafish. The platform can efficiently identify genes responsible for morphological or behavioral phenotypes. In one application, we showed that MIC-Drop could identify small-molecule targets. Furthermore, in a MIC-Drop screen of 188 poorly characterized genes, we discovered several genes important for cardiac development and function. With the potential to scale to thousands of genes, MIC-Drop enables genome-scale reverse genetic screens in model organisms.
No takes yet. Share an insight, caveat, or question.
Parvez et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: